Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease

Infection

Volumn 43, Issue 5, 2015, Pages 561-567

  Brandolini, Micaela ^a   Corbella, Marta ^a   De Silvestri, Annalisa ^a   Tinelli, Carmine ^a   Albonico, Giulia ^a   Albertini, Riccardo ^a   Ludovisi, Serena ^a   Bruno, Raffaele ^a   Marone, Piero ^a   Minoli, Lorenzo ^a   Seminari, Elena ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Bloodstream infection; Chronic hepatitis; Liver cirrhosis

Indexed keywords

ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; CHRONIC HEPATITIS; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION RATE; INFECTION RISK; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; CLASSIFICATION; COMPLICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; SEPSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

AGED; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84942553038     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-015-0794-6     Document Type: Article

References (27)

1. Mellencamp MA, Preheim LC. Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae. J Infect Dis. 1991;163(1):102–8.
2. Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol. 2007;102(7):1510–7.
3. Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310–24.
4. Brann OS. Infectious complications of cirrhosis. Curr Gastroenterol Rep. 2001;3(4):285–92.
5. Park HJ, Lee YM, Bang KM, Park SY, Moon SM, Park KH, et al. Clinical significance of Staphylococcus aureus bacteremia in patients with liver cirrhosis. Eur J ClinMicrobiol Infect Dis. 2012;31(12):3309–16.
6. Kuo CH, Changchien CS, Yang CY, Sheen IS, Liaw YF, et al. Bacteremia in patients with cirrhosis of the liver. Liver. 1991;11(6):334–9.
7. Kang CI, Song JH, Chung DR, Peck KR, Yeom JS, Ki HK, et al. Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia. J Infect. 2011;63(5):336–43.
8. Bartoletti M, Giannella M, Caraceni P, Domenicali M, Ambretti S, Tedeschi S, et al. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. J Hepatol. 2014;61(1):51–8.
9. Fernández Guerrero ML. González López J, Górgolas M. Infectious endocarditis in patients with cirrhosis of the liver: a model of infection in the frail patient. Eur J ClinMicrobiol. Infect Dis. 2010;29(10):1271–5.
10. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–26.
11. Sheth M, Riggs M, Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol. 2002;2:2.
12. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;29(338):b2393.
13. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Predictive scoring model of mortality in Gram-negative bloodstream infection. Clin Microbiol Infect. 2013;19(10):948–54.
14. Linderoth G, Jepsen P, Schønheyder HC, Johnsen SP, Sørensen HT. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: A population-based cohort study. Alcohol ClinExp Res. 2006;30(4):636–41.
15. Thulstrup AM, Sørensen HT, Schønheyder HC, Møller JK, Tage-Jensen U. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis. 2000;31(6):1357–61.
16. Campillo B, Richardet JP, Kheo T, Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis. 2002;35(1):1–10.
17. Runyon BA. Monomicrobial non neutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology. 1990;12:710–5.
18. Kuo CHL, Changchien CS, Yang CY, Sheen IS, Liaw YF. Bacteremia in patients with cirrhosis of the liver. Liver. 1991;11(6):334–9.
19. Caly WRL, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993;18(3):353–8.
20. Kang CI, Song JH, Ko KS, Chung DR, Peck KR. Clinical significance of Staphylococcus aureus infection in patients with chronic liver diseases. Liver Int. 2010;30(9):1333–8.
21. Squier C, Rihs JD, Risa KJ, Sagnimeni A, Wagener MM, Stout J, et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol. 2002;23(9):495–501.
22. Paterson DL, Rihs JD, Squier C, Gayowski T, Marino IR, Sagnemeni A, et al. Lack of efficacy of mupirocin in the prevention of infections with methicillin-resistant Staphylococcus aureus in liver transplant recipients and candidates. Transplantation. 2003;75:194–8.
23. Dupeyron C, Campillo B, Richardet JP, Soussy CJ. Long-term efficacy of mupirocin in the prevention of infections with methicillin-resistant Staphylococcus aureus in a gastroenterology unit. J Hosp Infect. 2006;63(4):385–92.
24. Falcone M, Concia E, Iori I, Lo Cascio G, Mazzone A, Pea F, et al. Identification and management of invasive mycoses in internal medicine: a road-map for physicians. Intern Emerg Med. 2014;9(5):501–11.
25. Leber B, Spindelboeck W, Stadlbauer V. Infectious complications of acute and chronic liver disease. SeminRespirCrit Care Med. 2012;33(1):80–95.
26. Hung TH, Hsieh YH, Tseng KC, Tsai CC, Tsai CC. The risk for bacterial endocarditis in cirrhotic patients: a population-based 3-year follow-up study. Int J Infect Dis. 2013;17(6):e391–3.
27. Fernández Guerrero ML. González López J, Górgolas M. Infectious endocarditis in patients with cirrhosis of the liver: a model of infection in the frail patient. Eur J Clin Microbiol Infect Dis. 2010;29(10):1271–5.